Home Injectables Merz Launches New Belotero® Revive Dermal Filler

Merz Launches New Belotero® Revive Dermal Filler

Merz Launches New Belotero® Revive Dermal Filler


FRANKFURT, Germany–(BUSINESS WIRE)–Merz, a global leader in medical aesthetics, today announced the launch
of Belotero® Revive, a dermal filler product containing a
unique combination of hyaluronic acid (HA) and glycerol, designed to
improve hydration, elasticity and firmness of the skin and to address
the appearance of fine lines.1,2 The newest addition to the
Belotero® dermal filler range, Belotero® Revive
was designed to meet the unique needs of today’s aesthetic patients.
Modern consumers are especially focused on skin quality and on
minimizing early signs of aging, and they value skincare and aesthetic
solutions that deliver natural-looking results – the so-called
“no-filter” look.

“We continue to see a growing interest in effective, high quality
injectable treatments from a new generation of aesthetic patients, due
in part to the influence of social media and other digital channels,”
stated Prof. Dr. Martina Kerscher, Professor of Dermatology, University
of Hamburg and lead author of the BELOVE study. “Strong scientific
research forms the basis for this new dermal injectable and our study
results show that treatment with this beauty booster is a an effective
way to provide direct skin hydration and increase skin smoothness,
giving our patients beautiful, natural-looking results.” 3,4

The new Belotero® Revive campaign encourages consumers to
“Show off the best version of yourself, without a filter!” The campaign
hints playfully at the influence of the digital sphere on real-life
moments and is designed to speak to the growing acceptance of aesthetic
medicine in different age groups, while encouraging female consumers to
make choices that bring out their own individual and natural beauty.

“Customer research and market trends make it clear that a new generation
of patients is increasingly open to aesthetic medicine and actively
looking for options to treat the first visible signs of aging,” stated
Philip Burchard, CEO of Merz. “At Merz, we have a strong focus on
researching and developing innovative and effective solutions that can
be used to address both specific patient needs and new market trends in
medical aesthetics. With Belotero® Revive, we are proud to be
able to provide aesthetic physicians with a new dermal injectable that
can be used for both early intervention and beautification, to help meet
the unique needs of individual patients.”

Belotero® Revive is now available in selected countries in
Europe and Latin America, with additional markets to be added later this
year. For more details, please visit BeloteroRevive.com
or follow @Merz_Aesthetics on Instagram.

Belotero® Revive builds upon the success of the
well-established Belotero® range, which includes a wider
selection of fillers which can correct imbalances and facial
volume-loss, define contours, lift, volumize, fill lines and wrinkles.
More information about the full Belotero® range is available
at global.belotero.com.

About Belotero® Revive

Belotero® Revive is applied via injection over multiple
treatments working as a beauty booster and for an overall youthful
radiance. It works beneath the skin to provide hydration but can also be
used to reduce the appearance of fine lines, or as a preventative and
early aesthetic intervention treatment to slow the progression of facial
changes over time.4 Belotero® Revive was
clinically assessed in a study involving 24 patients. Belotero®
Revive was injected into the lower cheek area of the face the treatment
options have been tested in an observation period of over 36 weeks.4

Results of the BELOVE study4

Belotero® Revive improves skin elasticity, has an excellent
safety profile, and a generally lower level of injection site pain

  • Up to 36 weeks improved skin hydration and reduced skin redness
  • 100% of patients showed improved aesthetic results at week 12
  • Over 80% of patients were satisfied with the treatment at week 24
  • 90% of patients would recommend Belotero® Revive to friends

About Merz

Merz is a global, family-owned aesthetics and neurotoxin company based
in Frankfurt, Germany. Privately-held for 110 years, the company is
distinguished by its commitment to innovation, long-term perspective and
focus on profitable growth. In addition to its comprehensive portfolio
of medical aesthetics products across the device, injectable and
skincare categories, Merz also develops neurotoxin therapy to treat
neurologically-induced movement disorders. In fiscal year 2017/18, Merz
generated revenue of EUR 1.024,4 million; the company has a total
workforce of 3,151 employees worldwide and a direct presence in 28
countries. More information is available at www.merz.com.

Copyright © 2019 Merz Pharma GmbH & Co. KGaA. All rights reserved. MERZ,
MERZ AESTHETICS and the MERZ logo are registered trademarks of Merz
Pharma GmbH & Co. KgaA.

1 HA in rejuvenation: Bukhari et al., Int J Biol
Macromolecules, 2018; 120:1682-1695
2 Glycerol and
hydration: Korponyai C et al., Acta Derm Venerol, 2017; 97:182-187
Belotero® Revive Instruction for use Version 3.0, 2018
Merz BELOVE Study, 2019


Source link